Fri.Sep 16, 2022

article thumbnail

Time to Glycemic Targets by 4-12 Weeks Reduced in Tirzepatide In Comparison to Other Therapies

Drug Topics

New research offers evidence that tirzepatide could help patients achieve glycemic goals.

496
496
article thumbnail

New data: The 340B program is driving up costs for patients and our health care system

PhRMA

Guess what? The 340B program grew, yet again, hitting a whopping $43.9 billion in sales at the discounted 340B price in 2021. But there has not been evidence of corresponding growth in care provided to vulnerable patients at 340B covered entities. And making matters worse, fresh data show that 340B may actually be driving up costs for some patients and our health care system as whole.

340
340
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Maternal Vaccination Cut the Risk of COVID-19 hospitalization for Infants

Drug Topics

Infants of fully vaccinated mothers had fewer cases of hospitalization from COVID-19 than those unvaccinated.

Hospitals 247
article thumbnail

Red Jacket: Fabio Gratton

PharmaVoice

The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

246
246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

News Roundup: September 11 to September 16

Drug Topics

Your weekly roundup of the latest news from Drug Topics®.

247
247
article thumbnail

Red Jacket: Udit Batra

PharmaVoice

A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.

246
246

More Trending

article thumbnail

Red Jacket: Jim Lang

PharmaVoice

The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

246
246
article thumbnail

STAT+: Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease

STAT

Intellia Therapeutics said Friday the first six patients to receive its CRISPR-based treatment for a genetic swelling disorder have safely had small, corrective changes made to dysfunctional DNA inside their liver cells. Preliminary results from the study — just the second to show that CRISPR-based gene editing can be delivered systemically and performed in vivo, or inside the body — found that the treatment, NTLA-2002, reduced levels of the disease-causing protein, kallikrein, by

142
142
article thumbnail

The 2022 Red Jacket honorees

PharmaVoice

Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

246
246
article thumbnail

The Impact of Prior Authorization on Patients With Cancer

Pharmacy Times

Prior authorizations have delayed time to treatment for patients and can directly impact clinical outcomes.

141
141
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Borrowing CAR-T tool from cancer therapy, lupus patients go into remission

STAT

Rheumatology — the study of immune-system-driven diseases of the bones, joints, muscles, and in-betweens — has inherited plenty of hand-me-downs from cancer research. For example, there are ways of squelching an immune system in order to shrink certain kinds of cancerous tumors. And scientists have found that, when retrofitted, those strategies can also alleviate some symptoms of autoimmune conditions.

article thumbnail

Gene Therapy Restores Some Vision in Colorblind Children

Pharmacy Times

Study suggests gene therapy may effectively treat young children who were born colorblind via pathways connecting the brain and the retina.

132
132
article thumbnail

At a fashion show for people with spinal muscular atrophy, models take back their own stories

STAT

NEW YORK — The scene: a fashion show on Fifth Avenue. The catwalk was not elevated, as it usually would be. People were packed tightly on benches alongside it in the dark. The first person to walk it was a singer/songwriter, James Ian, dressed in a flashy suit with a howling wolf embroidered in beadwork on the back. Ian walked with a slight limp.

137
137
article thumbnail

Red Jacket: Quita Highsmith

PharmaVoice

The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

130
130
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA Approves Daxxify for Temporary Improvement of Moderate to Severe Frown Lines

Pharmacy Times

DaxibotulinumtoxinA-lanm from Revance Therapeutics Inc is the first peptide-formulated neuromodulator with long-lasting results.

FDA 123
article thumbnail

Red Jacket: Peyton Howell

PharmaVoice

The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

130
130
article thumbnail

Study: Geographical Location May Be Associated With Certain Risk Factors, Cancer Mortality

Pharmacy Times

Researchers found differences in the variable importance of cancer mortality risk factors depending on an individual’s geographical region.

123
123
article thumbnail

BJ’s Wholesale Club to accept online SNAP EBT payments chainwide

Drug Store News

When using its SNAP EBT cards to shop online at BJs.com or on the BJ’s mobile app, members have the option of selecting from multiple delivery methods, including free pickup, shipping and same-day delivery.

112
112
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pharmacy Care Coaches Improve Outcomes in Patients With Diabetes

Pharmacy Times

Care Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.

123
123
article thumbnail

Downy Rinse & Refresh targets tough odors

Drug Store News

Downy Rinse & Refresh is a deep-cleansing fabric rinse designed to help remove odor-causing residues.

111
111
article thumbnail

Immune Thrombocytopenia Purpura Treatment Options Abound

Pharmacy Times

Corticosteroids are first-line therapy for gaining platelet stability but should only be used short term.

article thumbnail

What Does It Feel Like to Have Thyroid Disease?

The Thyroid Pharmacist

Before my Hashimoto’s diagnosis, I had always been very polite, and described myself as a “diplomat.”. People knew me as someone who maintained patience and composure in almost any situation. But for me, one of the reasons I suspected something was off with my health, was that I started experiencing mood swings in combination with starting to feel as though I was on an emotional roller coaster… yet felt numb…!

article thumbnail

Eating Disorders Are Notoriously Difficult to Treat

Pharmacy Times

Many drugs for these conditions enter clinical trials, but few demonstrate success.

123
123
article thumbnail

Opinion: The White House has a major chance to improve coordination of federal nutrition efforts

STAT

At the end of September, the White House will host a Conference on Hunger, Nutrition and Health , the first such conference in more than 50 years. Its goal is to accelerate progress toward ending hunger, improving nutrition and physical activity, and reducing diet-related disease. Given the ubiquity of contradictory and headline-grabbing information that can lead to confusion about what to eat or drink, progress on improving diets and the science underlying dietary recommendations is needed now

102
102
article thumbnail

Pharmacy Focus Episode 55: Advocating for Support as a Health Systems Pharmacist

Pharmacy Times

Using your voice as a health care professional and supporting each other through burnout are just a few ways to better advocate in the profession.

123
123
article thumbnail

Kroger expands delivery to Birmingham, Ala.

Drug Store News

Kroger opened a new spoke facility serving the southern region, and it expects to employ more than 160 new associates.

102
102
article thumbnail

FDA Approves Terlipressin to Improve Kidney Function in Hepatorenal Syndrome

Pharmacy Times

The drug improves kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.

FDA 107
article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. Lebrikizumab, a monoclonal antibody that inhibits an interleukin named IL-13, is especially promising in treatment of this disease.

article thumbnail

The meth crisis is worse than ever, but new treatments might be around the corner

STAT

When it comes to meth addiction, Thomas Robey has long been at a loss. As an emergency room doctor, he treats a steady stream of patients who show up at Providence Regional Medical Center in Everett, Wash., after experiencing a methamphetamine overdose.

98
article thumbnail

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

PharmExec

Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.

98
article thumbnail

STAT+: Humana appeases Wall Street with big projections of Medicare Advantage growth

STAT

Humana is targeting ambitious growth of its Medicare Advantage plans and primary care clinics over the next three years, which executives said Thursday will significantly propel Humana’s profitability. Humana’s stock price ended the day up 8%, valuing the company at $63 billion. The main purpose of Humana’s messaging was to comfort Wall Street over concerns the company was losing ground in the booming Medicare Advantage market.

article thumbnail

Is localisation the answer for pharmaceutical supply chain resilience?

European Pharmaceutical Review

We have reported several times on supply chain resilience since the start of the COVID-19 pandemic, 1-3 as the world experienced unprecedented lockdowns and supply disruptions, with interruptions to manufacturing as well as both air transportation and shipping routes. Since the developed regions of the world started to get COVID-19 under control, focus on this matter has only grown – particularly in the pharmaceutical sector, which played a critical role in curbing the devastation caused by the

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right.  Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

98